Collaborative Project of the 7th Framework Programme. WP6: Tools for bio-researchers and clinicians
|
|
- Magnus Griffith
- 5 years ago
- Views:
Transcription
1 G.A. nº Collaborative Project of the 7th Framework Programme WP6: Tools for bio-researchers and clinicians Deliverable 6.1: Design of Inference Engine v /10/2011
2 Document Information Project Number Acronym Synergy-COPD Full title Project URL EU Project officer Modelling and simulation environment for systems medicine (Chronic obstructive pulmonary disease -COPD- as a use case) Marta Lorens Deliverable Number 6.1 Title Design of Inference Engine Work package Number 6 Title Tools for bio-researchers and clinicians Date of delivery Contractual PM09 Actual PM09 Nature Dissemination Level Prototype Report Dissemination Other Restricted : Restricted: VPH partners and participants in VPH-related FP7 projects Document responsible Filip Velickovski fvelickovski@bdigital.org Partner BDIGITAL Phone Authors Name Partner Main author(s) Filip Velickovski BDIGITAL Luigi Ceccaroni BDIGITAL Co-author(s) Peter Somogy KI Isaac Cano Josep Roca LINKCARE IDIBAPS D 6 1 Inference Engine Design.2011_10_31_21 page 2 of 73
3 Abstract (for dissemination) Key words A CDSS can be defined as "software that is designed to be a direct aid to clinical decision-making in which the characteristics of an individual patient are matched to a computerized clinical knowledge base, and patientspecific assessments or recommendations are then presented to the clinician and/or the patient for a decision". One of the primary objectives in the Synergy-COPD project is to develop a CDSS so that medical staff (primary care clinicians, specialists, and/or nurses) can obtain fast, reliable and directly applicable advice when treating a patient with COPD. The Synergy-COPD CDSS will use mechanistic models, probabilistic models, and existing knowledge from specialists and other evidence-based sources in order to perform early diagnosis of the disease, prediction of disease progression, and personalized treatment-advice for patients. The purposes of this deliverable are to review the main types of CDSS that exist in research and in medical practice with a focus on the reasoning or inference methods, to specify the core requirements, assumptions and functionality of the CDSS to be developed in Synergy-COPD and to outline the main components that will form part of the Synergy-COPD CDSS design, and the plan to execute the work. clinical decision support, COPD, rules-based systems, inference engine, computer interpretable guidelines Version Log Issue Date Version Author Change 01/08/ Filip Velickovski Document skeleton started 15/08/ Filip Velickovski Bullet points of sections 27/09/ Filip Velickovski First draft released internally BDIGITAL 17/10/ Filip Velickovski Second draft released to consortium for comments 23/10/ Peter Somogy, Isaac Cano, Josep Roca Peter S typo fixes actualized, Isaac C suggestions taken into account, Josep R clinical clarifications actualized 27/10/ Filip Velickovski, Luigi Further updating of sections Ceccaroni 30/10/ Luigi Ceccaroni Luigi major revisions 31/10/ Filip Velickovski, Luigi Ceccaroni, Alba Grau Ready for submission D 6 1 Inference Engine Design.2011_10_31_21 page 3 of 73
4 Index 1 INTRODUCTION A NOTE OF CLARIFICATION A REVIEW OF CDSS CDSS CHARACTERIZATION REASONING METHODS Workflow driven Rule-based reasoning Probabilistic Reasoning (Bayesian networks) Pattern recognition and machine learning (PR and ML) Case based reasoning STATE OF THE ART OF CDSS IN COPD Literature search Analysis CDSS INFRASTRUCTURAL FEATURES Knowledge acquisition and authoring (KA) tools Electronic health records (EHRs) Communication interface between medical systems Medical vocabularies REQUIREMENTS SPECIFICATION FOR THE SYNERGY-COPD CDSS INITIAL USE CASE SCENARIO MOTIVATION CLINICAL CONTEXT CLINICAL KNOWLEDGE INFORMATION DELIVERY DECISION SUPPORT REQUIREMENTS Case finding Diagnosis D 6 1 Inference Engine Design.2011_10_31_21 page 4 of 73
5 3.6.3 Assessment Management Referral Exacerbation control SYNERGY-COPD CDSS DESIGN WORK STRATEGY CDSS ARCHITECTURE Internal components External systems CONCLUSIONS REFERENCES A. DEFINITIONS OF SPECIAL TERMS A.1 TERMINOLOGY CONFUSION: COPD, EMPHYSEMA, CHRONIC BRONCHITIS A.2 TERMINOLOGY CONFUSION: EMR, EHR, AND PHR A.3 COMORBIDITIES AND SYSTEMIC EFFECTS B. LIST OF ACRONYMS AND ABBREVIATIONS D 6 1 Inference Engine Design.2011_10_31_21 page 5 of 73
6 List of figures FIGURE 1 A GENERAL MODEL OF A KNOWLEDGE-BASED CDSS FIGURE 2 A FLOWCHART SHOWING A DIFFERENTIAL DIAGNOSIS OF COPD AND ASTHMA FROM THE NEW ZEALAND BEST PRACTICE ADVOCACY CENTRE FIGURE 3 GENERIC MODEL OF A WORKFLOW-DRIVEN CDSS FIGURE 4 PROFORMA TASK ONTOLOGY FIGURE 5 GLIF REPRESENTATION OF THE STABLE ANGINA GUIDELINE [24] FIGURE 6 GUIDE WORKFLOW FOR STROKE DIAGNOSIS FIGURE 7 INFERENCE ENGINE COMPONENTS OF GUIDE FIGURE 8 ACTIVITY DIAGRAM OF AN IMMUNIZATION GUIDELINE FOR HEPATITIS B FIGURE 9 DECISION MAP OF A CHILD IMMUNIZATION GUIDELINE FIGURE 10 GENERIC MODEL OF A RULE-BASED REASONING CDSS FIGURE 11 FORWARD CHAINING RULES MODEL FIGURE 12 BACKWARD CHAINING RULES MODEL FIGURE 13 HIGH BLOOD PRESSURE PROTOCOL FIGURE 14 A KNN EXAMPLE FIGURE 15 A FEED FORWARD THREE-LAYERED ARTIFICIAL NEURAL NETWORK FIGURE 16 THE CBR PARADIGM FIGURE 17 PREDICTIVE NETWORK OF COPD FIGURE 18 COPD IDENTIFICATION ALGORITHM FIGURE 19 SEGMENTED IMAGE OF LUNG FIGURE 20 EXAMPLES OF SPIROMETRY FLOW-VOLUME CURVES. (A) RESTRICTIVE (B) OBSTRUCTIVE (C) MIXED (D) NORMAL FIGURE 21 COPD DIAGNOSIS RULE FOR FUZZY VALUES FIGURE 22 FEEDBACK FROM ASTHMACRITIC FIGURE 23 DECISION SUPPORT AREAS OF ASTHMACRITIC [60] FIGURE 24 DECISION CRITERIA FOR PATIENT REFERRAL [62] FIGURE 25 KNOWLEDGE AND DATA IN THE CDSS ENVIRONMENT D 6 1 Inference Engine Design.2011_10_31_21 page 6 of 73
7 FIGURE 26 GUI OF THE RULES AUTHORING TOOL [71] FIGURE 27 CDSS SYSTEM COMPONENTS AND EXTERNAL SYSTEMS List of tables TABLE 1: CATEGORIES AND FEATURES OF A CDSS TABLE 2: ATTRIBUTES OF PROFORMA GENERIC TASKS TABLE 3: AREZZO APPLICATIONS TABLE 4: TALLIS APPLICATIONS TABLE 5: MODELLING ELEMENTS OF GLIF TABLE 6: LITERATURE SEARCH OF CDSSS FOR COPD TABLE 7: RELEVANT PUBLICATIONS FOR CLINICAL DECISION SUPPORT APPLICATIONS45 TABLE 8: TELEHEALTH PATIENT PARAMETERS USED IMPLEMENTED BY SYSTEMS D 6 1 Inference Engine Design.2011_10_31_21 page 7 of 73
8 1 Introduction Synergy-COPD is an EU Seventh Framework Program project to research, design, implement and validate a platform and methodology which will ultimately support clinicians to take more informed decisions. The disease used as pilot case study is chronic obstructive pulmonary disease (COPD), which is a major cause of chronic morbidity and mortality throughout the world [1]. COPD is a preventable and treatable disease characterized by airflow limitation that is not fully reversible and is mainly caused by smoking. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles. Although primarily a pulmonary disease, COPD has some extrapulmonary effects that may contribute to the severity in individual patients. Primary symptoms include cough, sputum production and dyspnea (shortness of breath) on exertion; episodes of acute worsening (exacerbation) of these symptoms often occur. The presence of systemic inflammation in COPD has been linked to a variety of complications, including weight loss, cachexia (wasting syndrome), osteoporosis, and cardiovascular diseases. An important problem in healthcare is the significant gap between optimal evidencebased medical practice and the care actually applied. In a systematic review [2] of COPD guideline adherence, it was found that non-pharmacological treatment was infrequently explored for the in-hospital management of COPD exacerbations, and the assessment and therapy were suboptimal. This trend exists not only in COPD but across all chronic-disease care in general: in a multinational survey [3] of chronically ill adults, 14-23% of cases reported at least one medical error in the previous two years. Clinical decision support systems (CDSSs), which aim to provide clinicians, staff, and patients with advice and personalized information, have the potential to enhance healthcare and health, and to help close the gap between optimal practice and actual clinical care. A CDSS can be defined as "software that is designed to be a direct aid to clinical decision-making in which the characteristics of an individual patient are matched to a computerized clinical knowledge base, and patient-specific assessments or recommendations are then presented to the clinician and/or the patient for a decision" [4]. One of the primary objectives in the Synergy-COPD project is to develop a CDSS so that medical staff (primary care clinicians, specialists, and/or nurses) can obtain fast, reliable and directly applicable advice when treating a patient with COPD. The Synergy-COPD CDSS will use models described in Deliverable 4.1 [5], probabilistic modelling (Deliverable 5.1 [6]), existing knowledge from specialists and other evidence-based sources in early diagnosis of the disease, prediction of disease progression, and personalized treatment-advice for patients. The purposes of this deliverable are: to review the main types of CDSS that exist in research and in medical practice with a focus on the reasoning or inference methods; to specify the core requirements, assumptions and functionality of the CDSS to be developed in Synergy-COPD; D 6 1 Inference Engine Design.2011_10_31_21 page 8 of 73
9 to outline the main components that will form part of the Synergy-COPD CDSS design, and the plan to execute the work. 1.1 A note of clarification In the title of this document (Design of Inference Engine) and in the context of WP6 [7], by the expression inference engine we mean the core reasoning engine and non-gui part of the CDSS. That includes components such as a guideline execution engine (GEE), a rules engine, a Bayesian inference engine, a case-based reasoning (CBR) engine. Hence from now on we will use the general expression reasoning engine as it better captures this intention. D 6 1 Inference Engine Design.2011_10_31_21 page 9 of 73
SAGE. Nick Beard Vice President, IDX Systems Corp.
SAGE Nick Beard Vice President, IDX Systems Corp. Sharable Active Guideline Environment An R&D consortium to develop the technology infrastructure to enable computable clinical guidelines, that will be
More informationAmerican Thoracic Society (ATS) Perspective
National Surveillance System for Chronic Lung Disease (CLD): American Thoracic Society (ATS) Perspective Gerard J. Criner, M.D. Chronic Obstructive Pulmonary Disease (COPD) l Definition: Group of chronic
More informationCARE OF THE ADULT COPD PATIENT
CARE OF THE ADULT COPD PATIENT Target Audience: The target audience for this clinical guideline is all MultiCare providers and staff including those associated with our Clinically Integrated Network. The
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationMULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient
Clinical Guideline Ver. 2.0 MULTICARE Health System Care of the Adult Chronic Obstructive Pulmonary Disease (COPD) Patient Target Audience: The target audience for this clinical guideline is all MHS providers
More informationChronic Obstructive Pulmonary Disease (COPD).
Chronic Obstructive Pulmonary Disease (COPD). Linde: Living healthcare 02 03 Chronic Obstructive Pulmonary Disease (COPD). A pocket guide for healthcare professionals. COPD the facts Moderate to severe
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationPathway diagrams Annex F
Pathway diagrams Annex F Fig 1 Asthma: The patient journey Asthma is diagnosed Making the diagnosis of asthma Confirming the diagnosis may depend on history, response to treatment, measurement of airflow
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationRespiratory diseases in Ostrołęka County
Respiratory diseases in Ostrołęka County 4400 persons underwent examination 950 persons were given referrals to more detailed investigation 600 persons were examined so far The results of more detailed
More informationQOF indicator area: Chronic Obstructive Pulmonary disease (COPD)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Cost impact statement: Chronic Obstructive Pulmonary Disease QOF indicator area:
More informationDisclosures. Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease May 14, 2016 Orlando, FL COPD (Chronic obstructive pulmonary disease) is a major cause of mortality and morbidity in the United States. Alarmingly, COPD recently became
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationChronic Obstructive Pulmonary Disease, shortened to COPD, is an umbrella term for a group of conditions which cause long-term damage to the airways.
10 Common QuESTIonS AbouT CoPD Chronic Obstructive Pulmonary Disease, shortened to COPD, is an umbrella term for a group of conditions which cause long-term damage to the airways. COPD includes: chronic
More informationASTHMA CARE FOR CHILDREN BASKET OF CARE SUBCOMMITTEE Report to: Minnesota Department of Health. June 22, 2009
This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp ASTHMA CARE FOR CHILDREN
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Chronic Obstructive Pulmonary Disease (COPD) is a slowly progressive disease of the airways that is characterized by a gradual loss of lung function. In the U.S.,
More informationPROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME
PROGRAMME INITIATION DOCUMENT MENTAL HEALTH PROGRAMME 1. BACKGROUND: 1.1 Primary Care 90% of mental health care is provided within primary care services, with the most common mental health problems identified
More informationFact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)
Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Jin S. Oh, PharmD Larkin Community Hospital January 10, 2016 Fact COPD is the third leading cause of death in the United
More informationCOPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
More informationBetter community respiratory care. Dr Roland Meyer Respiratory Physician Southern DHB August 2010
Better community respiratory care Dr Roland Meyer Respiratory Physician Southern DHB August 2010 Integration : What is needed? Raise profile of disease Strong management in primary care Good communication
More informationProject 3dii: Expansion of the Home Environmental Asthma Management Program
1 Project 3dii: Expansion of the Home Environmental Asthma Management Program Asthma Primary Care Project Participation Opportunity Purpose 2 This Project Participation Opportunity is specifically targeted
More informationGlobal Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health
Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline MedStar Health These guidelines are provided to assist physicians and other clinicians in making decisions
More informationTowards tailored and targeted asthma self-management using mobile technologies
Towards tailored and targeted asthma self-management using mobile technologies Funded by the European Union Asthma: the problem Asthma is a lifelong chronic disease caused by inflammation of the airways,
More informationChronic respiratory disease: towards better treatments
Chronic respiratory disease: towards better treatments Alaina J. Ammit PhD Alaina.Ammit@uts.edu.au Professor of Respiratory Pharmacology, UTS Director, Woolcock Emphysema Centre, Woolcock Institute of
More informationClinical decision support (CDS) and Arden Syntax
Clinical decision support (CDS) and Arden Syntax Educational material, part 1 Medexter Healthcare Borschkegasse 7/5 A-1090 Vienna www.medexter.com www.meduniwien.ac.at/kpa (academic) Better care, patient
More informationINTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME
INTRODUCTION TO THE REMOTE ASSESSMENT OF DISEASE AND RELAPSE (RADAR) PROGRAMME All information regarding future IMI Call topics is indicative and subject to change. Final information about future IMI Calls
More information9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationUnderstanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationDOWNLOAD OR READ : REVERSING CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : REVERSING CHRONIC OBSTRUCTIVE PULMONARY DISEASE COPD PDF EBOOK EPUB MOBI Page 1 Page 2 reversing chronic obstructive pulmonary disease copd reversing chronic obstructive pulmonary pdf
More informationCOPD: Preventable and Treatable. Lecture Outline. Diagnosis of COPD. COPD: Defining Terms
COPD: Preventable and Treatable Christopher H. Fanta, M.D. Partners Asthma Center Pulmonary and Critical Care Division Brigham and Women s Hospital Harvard Medical School Lecture Outline I. Diagnosis and
More informationDiscovery and validation of novel. Webinar IMI2 - Call 9 Joint influenza vaccine effectiveness studies
Discovery and validation of novel Webinar IMI2 - Call 9 Joint influenza vaccine effectiveness studies Dr. Angela Wittelsberger, IMI IMI webinar 29.04.2016 Today s webinar Will cover all aspects of the
More informationPOLICIES AND PROCEDURE MANUAL
POLICIES AND PROCEDURE MANUAL Policy: MP230 Section: Medical Benefit Policy Subject: Outpatient Pulmonary Rehabilitation I. Policy: Outpatient Pulmonary Rehabilitation II. Purpose/Objective: To provide
More informationAsthma COPD Overlap (ACO)
Asthma COPD Overlap (ACO) Dr Thomas Brown Consultant Respiratory Physician Thomas.Brown@porthosp.nhs.uk Dr Hitasha Rupani Consultant Respiratory Physician Hitasha.rupani@porthosp.nhs.uk What is Asthma
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationPromoting Drug Users Respiratory Health
Promoting Drug Users Respiratory Health Lloyd Baron IAD Research Assistant, Centre for Public Health, Liverpool John Moores University L.R.Baron@ljmu.ac.uk Outline Background terminology and COPD explanation
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More information2012 Chronic Respiratory. Program Evaluation. Our mission is to improve the health and quality of life of our members
2012 Chronic Respiratory Program Evaluation Our mission is to improve the health and quality of life of our members 2012 Chronic Respiratory Program Evaluation Program Title: Chronic Respiratory Program
More informationCOPD as a comorbidity of heart failure in elderly patients
COPD as a comorbidity of heart failure in elderly patients Professor Mitja Lainscak, MD, PhD, FESC, FHFA Departments of Cardiology and Research&Education, General Hospital Celje Faculty of Medicine, University
More informationA Framework for Optimal Cancer Care Pathways in Practice
A to Guide Care Cancer Care A for Care in Practice SUPPORTING CONTINUOUS IMPROVEMENT IN CANCER CARE Developed by the National Cancer Expert Reference Group to support the early adoption of the A to Guide
More informationOffice Asthma Care: Practical Elements of Asthma Management. Learning Objectives. Diagnosis
Office Asthma Care: Practical Elements of Asthma Management Pri-Med West Annual Conference March 29, 2014 Anaheim, CA Sande Okelo, MD, PhD, University of California Los Angeles sokelo@mednet.ucla.edu www.uclahealth.org/pedspulmonology
More informationCLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease
CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts
More informationYorkshire & Humber Respiratory Programme Report
2013 NHS Harrogate & Rural District Clinical Commissioning Group Yorkshire & Humber Respiratory Programme Report This report has been produced by the Yorkshire & Humber Respiratory Team. It highlights
More informationNEWSLETTER Partners. 43 Months WPs Deliverables. 8 Use Cases Companies RTDs. Contents. Keywords
Welcome to the first issue of the OActive Newsletter! NEWSLETTER Issue 1: December 2018 Contents 1. OActive at a glance 2. OActive website, video & milestones 3. OActive Physical Meetings 4. Attendance
More informationAsthma Tutorial. Trainer MRW. Consider the two scenarios, make an attempt at the questions, what guidance have you used?
Registrar: LG PR RS Topic Asthma and COPD Asthma Tutorial Trainer MRW Date of Tutorial 18 th Jan 2007 Objectives of the tutorial How to diagnose What investigations and when Treatment guidelines QoF Criteria
More information10/22/2013. The Dartmouth Spine Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH
0/22/203 October 3, 203 International Society for Quality in Health Care Patient Reported Outcomes: Hospitals and Clinicians Perspective. There is a growing interest in the development of new outcome measures
More information7.2 Part VI.2 Elements for a Public Summary
7.2 Part VI.2 Elements for a Public Summary 7.2.1 Part VI.2.1 Overview of disease epidemiology Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation that is usually
More informationFatigue in COPD. Dr. Jan Vercoulen, Clinical Psychologist. Dpt. Medical Psychology Radboud University Nijmegen Medical Center
Fatigue in COPD Dr. Jan Vercoulen, Clinical Psychologist Dpt. Medical Psychology Radboud University Nijmegen Medical Center Definition COPD GOLD, 2016 Chronic Obstructive Pulmonary Disease = common preventable
More informationSPECIFICATION FINAL. Electronic Medical Records. Appendix C Chronic Disease Management Requirements. OntarioMD Inc.
OntarioMD Inc. Electronic Medical Records SPECIFICATION Appendix C Chronic Disease Management Requirements FINAL Date: January 17, 2011 Version: 4.0 2007-2011 OntarioMD Inc. All rights reserved TABLE OF
More informationJOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES
JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES Authors Dr Ian Benton Respiratory Consultant COCH Penny Rideal Respiratory Nurse COCH Kirti Burgul Respiratory Pharmacist COCH Pam
More informationYorkshire & Humber Respiratory Programme Report
2013 NHS Bassetlaw Clinical Commissioning Group Yorkshire & Humber Respiratory Programme Report This report has been produced by the Yorkshire & Humber Respiratory Team. It highlights opportunities that
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #51 (NQF 0091): Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY
More informationClinical Decision Support Systems. 朱爱玲 Medical Informatics Group 24 Jan,2003
Clinical Decision Support Systems 朱爱玲 Medical Informatics Group 24 Jan,2003 Outline Introduction Medical decision making What are clinical decision support systems (CDSSs)? Historical perspective Abdominal
More informationWhat s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM
What s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM Covering: Basic Definition New assessment criteria Some newer treatments BiPAP Not Covering: Definitions: Chronic Obstructive Pulmonary
More informationPROMOTION OF PHYSICAL ACTIVITY
General objective Resources «Living Well with COPD» Reference guide for individual patient education «Integrating physical activity and/or an exercise program into your life», Section Promotion of physical
More information1st Turku Traumatic Brain Injury Symposium Turku, Finland, January 2014
The TBIcare decision support tool aid for the clinician Jyrki Lötjönen & Jussi Mattila, VTT Technical Research Centre of Finland Validation of the decision support tool Ari Katila University of Turku 1st
More informationIntegrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations. Dr Christina MAW Hospital Authority, Hong Kong
Integrating Medical and Social Support for Elderly System & Technology Enabled Service Innovations Dr Christina MAW Hospital Authority, Hong Kong Hospital Authority (HA) of Hong Kong A statutory body responsible
More informationCOPD in primary care: reminder and update
COPD in primary care: reminder and update Managing COPD continues to be a major feature of primary care, particularly in practices with a high proportion of M ori and Pacific peoples. COPDX clinical practice
More informationSmoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014
Smoking Counselling and Cessation Service in Hospital Authority 7 May 2014 - HA Convention 2014 On behalf of COC (Family Medicine) Dr Maria Leung Consultant, Department of Family Medicine New Territories
More informationOldham Exercise Referral Scheme
OLDHAM COMMUNITY LEISURE Oldham Exercise Referral Scheme April 2015 Exercise Referral Scheme April 2015 From April 2015 Oldham Community will be changing the format of delivery of the Exercise Referral
More informationCOPD. Breathing Made Easier
COPD Breathing Made Easier Catherine E. Cooke, PharmD, BCPS, PAHM Independent Consultant, PosiHleath Clinical Associate Professor, University of Maryland School of Pharmacy This program has been brought
More informationScreening for chronic obstructive pulmonary disease (COPD) in the general adult population
Screening for chronic obstructive pulmonary disease (COPD) in the general adult population External review against programme appraisal criteria for the UK National Screening Committee Version: FINAL Author:
More informationChronic obstructive pulmonary disease
0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find
More informationManagement of Acute Exacerbations of COPD
MiCMRC Educational Webinar Management of Acute Exacerbations of COPD August 22, 2018 MiCMRC Educational Webinar Management of Acute Exacerbations of COPD Expert Presenter: Catherine A. Meldrum PhD RN MS
More informationChronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc..
Add your company logo here Chronic Obstructive Learning Collaborative Sponsored by AMGA and Boehringer Ingelheim Pharmaceuticals, Inc.. November 10-12 2010 Dallas, TX GEISINGER HEALTH SYSTEM INCORPORATING
More informationBoard Meeting &General Assembly 30 November 1 December Value of Treatment for Brain Disorders Research Project
Board Meeting &General Assembly 30 November 1 December 2016 Value of Treatment for Brain Disorders Research Project Brain neuropsychiatic - disorders represent an enormous threat Highly prevalent and disabling
More informationAn Overview of Asthma - Diagnosis and Treatment
An Overview of Asthma - Diagnosis and Treatment Definition of Asthma: Asthma is a common chronic disease of children and adults. Nationally, more than 1 in 14 Americans report having asthma and as many
More informationChronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease 07 Contributor Dr David Tan Hsien Yung Definition, Diagnosis and Risk Factors for (COPD) Differential Diagnoses Goals of Management Management of COPD THERAPY AT EACH
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #52 (NQF 0102): Chronic Obstructive Pulmonary Disease (COPD): Long-Acting Inhaled Bronchodilator Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL
More information7.Integrating quit lines into health systems
7.Integrating quit lines into health systems Why should quit-line planners, promoters and service providers consider how their quit line could be integrated into health-care delivery systems in their country?
More informationPRESCRIBING BY RADIOGRAPHERS: A VISION PAPER
PRESCRIBING BY RADIOGRAPHERS: A VISION PAPER 1 INTRODUCTION 1.1 The Review of Prescribing, Supply & Administration of Medicines (Crown II) Final Report was submitted to The Secretary of State for Health
More informationPeople with asthma who smoke. The combination of asthma, a chronic airway disease, and smoking increases the risk of COPD even more.
COPD Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, sputum (phlegm) production
More informationChronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) Health Promotion and Education Program Rev. 2014 2014, MMM Healthcare, Inc. - PMC Medicare Choice, Inc. Reproduction of this material is prohibited. MP-HEP-PPT-200-01-021914-E
More informationPROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary
CBD Distr. GENERAL UNEP/CBD/COP/11/31 30 July 2012 ORIGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY Eleventh meeting Hyderabad, India, 8 19 October 2012 Item 3.2 of
More informationDesigning CME to Change Competence, Performance and Patient Outcomes
Designing CME to Change Competence, Performance and Patient Outcomes Learning Objectives After participating in this module, learners should be able to Differentiate between knowledge, competence, and
More informationImproving access to pulmonary rehabilitation through Medicare Benefit Scheme subsidies
Improving access to pulmonary rehabilitation through Medicare Benefit Scheme subsidies FREQUENTLY ASKED QUESTIONS Contents: About Lung Foundation Australia s Medicare Benefit Scheme Application Page 1
More informationHow to distinguish between uncontrolled and severe asthma
How to distinguish between uncontrolled and severe asthma Watch patient using their inhaler. Discuss adherence and barriers to use Compare inhaler technique with a devicespecific checklist, and correct
More informationWEBINAR. Difficult-to-treat and severe asthma: changing the paradigm
WEBINAR Difficult-to-treat and severe asthma: changing the paradigm A multidisciplinary discussion on new therapies, and how to identify and manage difficult-to-treat and severe asthma DIFFICULT-TO-TREAT
More informationDevelopment of novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) and patients with non-cf bronchiectasis (BE)
Development of novel inhaled antibiotic regimens in patients with cystic fibrosis (CF) and patients with non-cf bronchiectasis (BE) Dr. Juliane Bernholz, Novartis (Coordinator) Dr. Andrea Appenzeller,
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More informationUsing Pay-for-Performance to Improve COPD Care MHC64474 SV64474
Using Pay-for-Performance to Improve COPD Care MHC64474 SV64474 1 Session Objectives Discuss Chronic Obstructive Pulmonary Disease (COPD), its impact and opportunities for improved care Review Pay for
More informationSurveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved.
Surveillance report 2016 Chronic obstructive pulmonary disease in over 16s: diagnosis and management (2010) NICE guideline CG101 Surveillance report Published: 6 April 2016 nice.org.uk NICE 2016. All rights
More informationR Jagdeesh Kanan* et al. International Journal of Pharmacy & Technology
ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com FACIAL EMOTION RECOGNITION USING NEURAL NETWORK Kashyap Chiranjiv Devendra, Azad Singh Tomar, Pratigyna.N.Javali,
More informationOptimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center
Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center dtaylor@ochsner.org Observations from Yesterday EPIC is epidemic No EMR No Way!!! Accountability/Benchmarking
More informationPresented by UIC College of Nursing
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long-acting inhalers and emergency use inhalers.
More informationChronic Obstructive Pulmonary Disease 1/18/2018
Presented by UIC College of Nursing Describe COPD. Identify red flags for a COPD exacerbation. Identify COPD triggers or risk factors. Differentiate between long acting inhalers and emergency use inhalers.
More informationChronic Obstructive Pulmonary Disease (COPD) Measures Document
Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number
More informationCOPD. Helen Suen & Lexi Smith
COPD Helen Suen & Lexi Smith What is COPD? Chronic obstructive pulmonary disease: a non reversible, long term lung disease Characterized by progressively limited airflow and an inability to perform full
More informationERS School and postgraduate education
37 ERS School and postgraduate education Introduction i Key points The ERS School s aim is to develop educational programmes and training opportunities in respiratory medicine for physicians and allied
More informationConvergence of Forces Driving Change in Today s Healthcare System
Convergence of Forces Driving Change in Today s Healthcare System Double # of people >60 by 2050 Shortage of qualified healthcare professionals Healthcare costs rising to unsustainable levels new models
More informationCOPD: A EUROPEAN PROBLEM WITH EUROPEAN SOLUTIONS
COPD: A EUROPEAN PROBLEM WITH EUROPEAN SOLUTIONS THE ERS actions to fight COPD Professor Nikos M. Siafakas MD, PhD Medical School, University of Crete President of the European Respiratory Society Dedicated
More informationProcess for appraising orphan and ultra-orphan medicines and medicines developed specifically for rare diseases Effective from September 2015
Introduction Process for appraising orphan and ultra-orphan medicines and medicines developed specifically for rare diseases Effective from September 2015 From September 2015 the All Wales Medicines Strategy
More informationCase-Compare Impact Report
Case-Compare Impact Report October 8, 20 For CME Activity: Developed through an independent educational grant from Genentech: Moderate to Severe Persistent Asthma: A Case-Based Panel Discussion (March
More informationPresenters: Robin Newhouse Steven Goodman David Hickam
Managing the Mass of Measures: Real People s Real Data Made Useful PCORI Methodology Report: Setting the Standard(s) for Rigorous, Patient- Centered Research June 3, 2014 12:00 1:00 pm EDT Presenters:
More informationProvider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More informationQuality Improvement through HIT
Quality Improvement through HIT What is quality in healthcare? Safe Effective Patientcentered Timely Efficient Equitable Overview Reinforce a vision for using HIT to improve quality Share our approach
More informationEpidemiology of COPD Prof. David M. Mannino, M.D.
Epidemiology of COPD David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health College of Public Health University of Kentucky 1 Outline Definitions Severity Progression
More informationIBM Patient Care and Insights: Utilizing Analytics to Deliver Impactful Care Management
IBM Patient Care and Insights: Utilizing Analytics to Deliver Impactful Care Management Healthcare Transformation: A Work in Progress 1st US rank in Healthcare spending 1 8.0 Hours each day an average
More information